Intralesional human chorionic gonadotropin for Kaposi's sarcoma [2] (multiple letters)

New England Journal of Medicine

Volumn 336, Issue 16, 1997, Pages 1187-1189

  Harris, P J ^a   Russo, I H ^a   Grulich, A E ^a   Kaldor, J M ^a   Gill, P S ^a   Lunardi Iskandar, Y ^a   Gallo, R C ^a   Krown, S E ^a   Rabkin, C S ^a  

^a AIDS Clinical Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; ANTINEOPLASTIC ACTIVITY; CLINICAL ARTICLE; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; KAPOSI SARCOMA; LETTER; PRIORITY JOURNAL; SKIN CANCER; TREATMENT OUTCOME; ANIMAL; APOPTOSIS; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; EXPERIMENTAL NEOPLASM; NOTE; RAT; FEMALE; HOMOSEXUALITY; INCIDENCE; MALE; SEX DIFFERENCE; DOSE RESPONSE; HUMAN HERPESVIRUS 8; VIROLOGY;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CHORIONIC GONADOTROPIN; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; SARCOMA, KAPOSI; TUMOR CELLS, CULTURED; ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; HOMOSEXUALITY, MALE; INCIDENCE; MALE; SEX FACTORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HERPESVIRUS 8, HUMAN; INJECTIONS, INTRALESIONAL;

EID: 0039917722     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199704173361614     Document Type: Letter

References (0)